![Katherine Priestman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 79 700 $ am 31.05.2026
Ms. Katherine S.
Priestman is a Chief Corporate & External Affairs Officer at CSL Ltd. and a Senior Independent Non-Executive Director at Oxford Nanopore Technologies Plc.
She is on the Board of Directors at Oxford Nanopore Technologies Plc, GlaxoSmithKline Intellectual Property (No.
4) Ltd., GlaxoSmithKline Intellectual Property (No.
3) Ltd., GlaxoSmithKline Intellectual Property (No.2) Ltd., GlaxoSmithKline Intellectual Property Development Ltd., GlaxoSmithKline Intellectual Property Management Ltd. and Royal Botanical Gardens.
Ms. Priestman was previously employed as a SVP-Portfolio, Research & Development Strategy by GSK Plc.
She also served on the board at GlaxoSmithKline Intellectual Property Ltd. She received her undergraduate degree from The University of Nottingham.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2025 | 41’290 ( 0% ) | 79 700 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Direktor/Vorstandsmitglied | 13.07.2023 |
| CSL LIMITED | Corporate Officer/Principal | 01.09.2023 |
GlaxoSmithKline Intellectual Property Management Ltd.
 GlaxoSmithKline Intellectual Property Management Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Direktor/Vorstandsmitglied | - |
GlaxoSmithKline Intellectual Property (No.2) Ltd.
 GlaxoSmithKline Intellectual Property (No.2) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Direktor/Vorstandsmitglied | 09.12.2016 |
Glaxosmithkline Intellectual Property Development Ltd.
 Glaxosmithkline Intellectual Property Development Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | 09.12.2016 |
GlaxoSmithKline Intellectual Property (No. 3) Ltd.
 GlaxoSmithKline Intellectual Property (No. 3) Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development, enhancement, maintenance, protection and exploitation of intellectual properties | Direktor/Vorstandsmitglied | 24.07.2018 |
GlaxoSmithKline Intellectual Property (No. 4) Ltd.
 GlaxoSmithKline Intellectual Property (No. 4) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines, vaccines and consumer healthcare products | Direktor/Vorstandsmitglied | 11.12.2018 |
Royal Botanical Gardens | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
GlaxoSmithKline Intellectual Property Ltd.
 GlaxoSmithKline Intellectual Property Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Direktor/Vorstandsmitglied | 28.10.2022 |
| ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Oxford Nanopore Technologies Plc
 Oxford Nanopore Technologies Plc Electronic Equipment/InstrumentsElectronic Technology Develops instruments for electronic detection and analysis of molecules | Electronic Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Botanical Gardens | |
GlaxoSmithKline Intellectual Property (No.2) Ltd.
GlaxoSmithKline Intellectual Property (No.2) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
GlaxoSmithKline Intellectual Property Management Ltd.
GlaxoSmithKline Intellectual Property Management Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
Glaxosmithkline Intellectual Property Development Ltd.
Glaxosmithkline Intellectual Property Development Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
GlaxoSmithKline Intellectual Property Ltd.
GlaxoSmithKline Intellectual Property Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
GlaxoSmithKline Intellectual Property (No. 3) Ltd.
GlaxoSmithKline Intellectual Property (No. 3) Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development, enhancement, maintenance, protection and exploitation of intellectual properties | Commercial Services |
GlaxoSmithKline Intellectual Property (No. 4) Ltd.
GlaxoSmithKline Intellectual Property (No. 4) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines, vaccines and consumer healthcare products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
